• Contents
• Letter of transmittal
• User guide
• Part 1: Overview
• Part 2: Highlights of 2010–2011
  • 2.1 Snapshot of the blood sector in 2010–11
  • 2.2 General Manager’s review
  • 2.3 NBA Board report
  • 2.4 Principal Medical Officer’s review
• Part 3: Performance
• Part 4: Horizon scanning
• Part 5: Corporate governance
• Part 6: Financial management and accountability
• Appendices

Part TWO: HIGHLIGHTS OF 2010–2011

2.1 Snapshot of the blood sector in 2010–11

Vital statistics

	2010–11	Change from 2009–10	Amount issued in 2011 (per 1000 head of population)	International comparison (per 1000 head of population)
Number of blood supply contracts managed by NBA	14	2	NA	NA
IVIg patients treated	11,408	1,568	NA	NA
Grams of IVIg issued	2,950,370.5	295,186.4	132.22	57–131 range from NPPSpa1 (2009–10)
Number of patients with bleeding disorders registered	4,680	Not known	NA	NA
International Units of Factor VIII issued	157,350,199	15,656,730	7,050.82	5,610 Average for 2009–10 NPPSpa1
Red cells issued (units)	800,570	4,706	35.92	2008 average from CoE 41 (range 9–60)3
Platelets issued (units)	134,705	6,293	6.02	2008 average from selected CoE countries 4.4 (range 2.8–7.0)3
FFP issued (litres)	47,209.5	106.1	7.22	2008 average from selected CoE 9.4 (range 0.3–16.4)3

Notes:
1. Collaboration of National Plasma Product Supply Planners
2. Populations calculated using the ABS catalogue 3222.0 Series B
3. CoE—Council of Europe. From the The Collection, Testing and Use of Blood and Blood Components in Europe 2008 report.

Other major achievements for the sector and the NBA in 2010–11:

• finalised the tender process for imported plasma and recombinant products with significant savings to governments in the cost of treatment of haemophilia patients
• implemented BloodNet, a national online blood ordering system, in 32 sites in South Australia, Tasmania, the Northern Territory, and selected sites in Victoria (the whole of Queensland has already been implemented)
• released the first module of the Patient Blood Management Guideline—Critical Bleeding/Massive Transfusion
• implemented output based funding for the Blood Service, a model which provides improved accountability and greater transparency for government funding
• received ministerial agreement for the Statement on national stewardship expectations for the supply of blood and blood products, which outlines expectations for those ordering and receiving blood products
• the government-funded new purpose-built Sydney blood and blood products processing and distribution centre for NSW and the ACT was completed for the Blood Service
• published the inaugural Australian Bleeding Disorders Registry (ABDR) Annual Report
• published the IVIg Annual Report
• completed two research projects (Blood sector research strategy preliminary gap analysis, and Impediments to better practice in demand management in the blood sector) commissioned by the Department of Health and Ageing (DoHA), to inform the Australian blood sector of options to improve demand management.